Publication:
Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children.

dc.contributor.authorTagarro, Alfredo
dc.contributor.authorCobos-Carrascosa, Elena
dc.contributor.authorVillaverde, Serena
dc.contributor.authorSanz-Santaeufemia, Francisco-Javier
dc.contributor.authorGrasa, Carlos
dc.contributor.authorSoriano-Arandes, Antoni
dc.contributor.authorHernanz, Alicia
dc.contributor.authorNavarro, María Luisa
dc.contributor.authorPino, Rosa
dc.contributor.authorEpalza, Cristina
dc.contributor.authorBatista, Rosa
dc.contributor.authorRizo, Jana
dc.contributor.authorIglesias-Bouzas, María-Isabel
dc.contributor.authorRodríguez-Molino, Paula
dc.contributor.authorVillanueva-Medina, Sara
dc.contributor.authorCarrasco-Colom, Jaime
dc.contributor.authorAlonso-Cadenas, José-Antonio
dc.contributor.authorMellado, María-José
dc.contributor.authorHerrero, Blanca
dc.contributor.authorMelendo, Susana
dc.contributor.authorDe La Torre, Mercedes
dc.contributor.authorCalleja, Lourdes
dc.contributor.authorCalvo, Cristina
dc.contributor.authorUrretavizcaya-Martínez, María
dc.contributor.authorAstigarraga, Itziar
dc.contributor.authorMenasalvas, Ana
dc.contributor.authorPenin, María
dc.contributor.authorNeth, Olaf
dc.contributor.authorBerzosa, Arantxa
dc.contributor.authorDe Ceano-Vivas, María
dc.contributor.authorVidal, Paula
dc.contributor.authorRomero, Isabel
dc.contributor.authorGonzález, Raúl
dc.contributor.authorGarcía, María Luz
dc.contributor.authorMesa, Juan-Miguel
dc.contributor.authorBallesteros, Álvaro
dc.contributor.authorBernardino, María
dc.contributor.authorMoraleda, Cinta
dc.contributor.authorEPICO-AEP Working Group
dc.date.accessioned2023-05-03T13:30:31Z
dc.date.available2023-05-03T13:30:31Z
dc.date.issued2021-11-05
dc.description.abstractWe aimed to identify the spectrum of disease in children with COVID-19, and the risk factors for admission in paediatric intensive care units (PICUs). We conducted a multicentre, prospective study of children with SARS-CoV-2 infection in 76 Spanish hospitals. We included children with COVID-19 or multi-inflammatory syndrome (MIS-C) younger than 18 years old, attended during the first year of the pandemic. We enrolled 1200 children. A total of 666 (55.5%) were hospitalised, and 123 (18.4%) required admission to PICU. Most frequent major clinical syndromes in the cohort were mild syndrome (including upper respiratory tract infection and flu-like syndrome, skin or mucosae problems and asymptomatic), 44.8%; bronchopulmonary syndrome (including pneumonia, bronchitis and asthma flare), 18.5%; fever without a source, 16.2%; MIS-C, 10.6%; and gastrointestinal syndrome, 10%. In hospitalised children, the proportions were 28.5%, 25.7%, 16.5%, 19.1% and 10.2%, respectively. Risk factors associated with PICU admission were age in months (OR: 1.007; 95% CI 1.004 to 1.01), MIS-C (OR: 14.4, 95% CI 8.9 to 23.8), chronic cardiac disease (OR: 4.8, 95% CI 1.8 to 13), asthma or recurrent wheezing (OR: 2.5, 95% CI 1.2 to 5.2) and after excluding MIS-C patients, moderate/severe liver disease (OR: 8.6, 95% CI 1.6 to 47.6). However, asthmatic children were admitted into the PICU due to MIS-C or pneumonia, not due to asthma flare.Conclusion: Hospitalised children with COVID-19 usually present as one of five major clinical phenotypes of decreasing severity. Risk factors for PICU include MIS-C, elevation of inflammation biomarkers, asthma, moderate or severe liver disease and cardiac disease. What is Known: • All studies suggest that children are less susceptible to serious SARS-CoV-2 infection when compared to adults. Most studies describe symptoms at presentation. However, it remains unclear how these symptoms group together into clinically identifiable syndromes and the severity associated with them. What is New: • We have gathered the primary diagnoses into five major syndromes of decreasing severity: MIS-C, bronchopulmonary syndrome, gastrointestinal syndrome, fever without a source and mild syndrome. Classification of the children in one of the syndromes is unique and helps to assess the risk of critical illness and to define the spectrum of the disease instead of just describing symptoms and signs.
dc.identifier.doi10.1007/s00431-021-04306-6
dc.identifier.essn1432-1076
dc.identifier.pmcPMC8568563
dc.identifier.pmid34738173
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568563/pdf
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007/s00431-021-04306-6.pdf
dc.identifier.urihttp://hdl.handle.net/10668/20086
dc.issue.number3
dc.journal.titleEuropean journal of pediatrics
dc.journal.titleabbreviationEur J Pediatr
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number1105-1115
dc.pubmedtypeJournal Article
dc.pubmedtypeMulticenter Study
dc.rights.accessRightsopen access
dc.subjectCOVID-19
dc.subjectChildren
dc.subjectClinical phenotypes
dc.subjectMIS-C
dc.subjectSARS-CoV-2
dc.subjectSeverity
dc.subject.meshAdolescent
dc.subject.meshCOVID-19
dc.subject.meshHumans
dc.subject.meshProspective Studies
dc.subject.meshRisk Factors
dc.subject.meshSARS-CoV-2
dc.subject.meshSystemic Inflammatory Response Syndrome
dc.titleClinical spectrum of COVID-19 and risk factors associated with severity in Spanish children.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number181
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC8568563.pdf
Size:
1.24 MB
Format:
Adobe Portable Document Format